Seeing Is Believing
AMGN is currently covered by 24 analysts with an average price target of $318.99. This is a potential upside of $34.32 (12.06%) from yesterday's end of day stock price of $284.67.
Amgen's activity chart (see below) currently has 535 price targets and 478 ratings on display. The stock rating distribution of AMGN is 40.23% HOLD, 50.57% BUY and 9.2% SELL.
Analysts average stock forecasts to be materialized ratio is 86.77% with an average time for these price targets to be met of 570.43 days.
Highest price target for AMGN is $380, Lowest price target is $215, average price target is $316.3.
Most recent stock forecast was given by TIM ANDERSON from BAML on 23-Jul-2025.
Amgen is a biotechnology company that specializes in developing, manufacturing, and delivering human therapeutics.
The company’s research focuses on six main therapeutic areas, which include inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Amgen produces drugs such as Enbrel, Neulasta, Prolia, Xgeva, Aranesp, KYPROLIS, and Repatha, which treat anemia, cardiovascular disease, multiple myeloma, osteoporosis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.
Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.
Currently out of the existing stock ratings of AMGN, 35 are a HOLD (40.23%), 44 are a BUY (50.57%), 8 are a SELL (9.2%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$261
$-34.1 (-11.56%)
$294
15 days ago
(23-Jul-2025)
4/6 (66.67%)
$-48.22 (-15.59%)
89
Hold
$305
$9.9 (3.35%)
$295
16 days ago
(22-Jul-2025)
9/10 (90%)
$-0.69 (-0.23%)
502
Hold
$326
$30.9 (10.47%)
$200
17 days ago
(21-Jul-2025)
2/4 (50%)
$30.13 (10.18%)
49
Buy
$328
$32.9 (11.15%)
$328
1 months 11 days ago
(27-Jun-2025)
1/4 (25%)
$50.87 (18.36%)
54
Hold
$280
$-15.1 (-5.12%)
$235
3 months ago
(07-May-2025)
17/21 (80.95%)
$4.16 (1.51%)
406
What is AMGN (Amgen) average time for price targets to be met?
Which analyst has the current highest performing score on AMGN (Amgen) with a proven track record?
Which analyst has the most public recommendations on AMGN (Amgen)?
Which analyst is the currently most bullish on AMGN (Amgen)?
Which analyst is the currently most reserved on AMGN (Amgen)?